---
source: federal-register
document_id: "2025-24155"
title: "Revocation of Two Authorizations of Emergency Use of In Vitro Diagnostic Devices for Detection and/or Diagnosis of COVID-19; Availability"
agencies: ["Health and Human Services Department", "Food and Drug Administration"]
published: 2026-01-02
fetched: 2026-01-04
type: notice
url: https://www.federalregister.gov/documents/2026/01/02/2025-24155/revocation-of-two-authorizations-of-emergency-use-of-in-vitro-diagnostic-devices-for-detection-andor
---

## Abstract
The Food and Drug Administration (FDA) is announcing the revocation of the Emergency Use Authorizations (EUAs) (the Authorizations) issued to Pfizer Inc. for the Lucira by Pfizer COVID-19 & Flu Test and Lucira by Pfizer COVID-19 & Flu Home Test. FDA revoked the Authorizations under the Federal Food, Drug, and Cosmetic Act (FD&C Act) as requested by the Authorization holder. The revocations, which include an explanation of the reasons for each revocation, are reprinted at the end of this document.

## Key Details
- **Type:** notice
- **Agencies:** Health and Human Services Department, Food and Drug Administration
- **Published:** 2026-01-02
- **Source:** [federal-register](https://www.federalregister.gov/documents/2026/01/02/2025-24155/revocation-of-two-authorizations-of-emergency-use-of-in-vitro-diagnostic-devices-for-detection-andor)
